ustransplant.org -- Transplant Statistics Reference Tables

Transplant Statistics: Annual Report : Reference Tables

Table 6.6d

Immunosuppression Use: Antirejection Treatment from Transplant

to One Year Post Transplant, 1991 to 2000

Recipients with Pancreas Transplant Alone (PTA) Transplants

		Year of Transplant
		1991	1992	1993	1994	1995	1996	1997	1998	1999	2000
Transplants		40	35	52	39	41	53	78	88	134	137
Tx with Antirejection Treatments		22	19	16	17	23	22	22	21	32	24
Antibodies	Category Usage	81.8%	100.0%	75.0%	70.6%	56.5%	54.5%	63.6%	52.4%	84.4%	95.8%
	ALG	22.7%	63.2%	37.5%	17.6%	4.3%	0.0%	0.0%	0.0%	0.0%	0.0%
	ATG	0.0%	0.0%	0.0%	5.9%	4.3%	36.4%	18.2%	9.5%	0.0%	0.0%
	NRATG/NRATS	0.0%	0.0%	0.0%	0.0%	0.0%	4.5%	0.0%	0.0%	0.0%	0.0%
	OKT3	63.6%	68.4%	56.3%	64.7%	52.2%	40.9%	54.5%	47.6%	68.8%	62.5%
	Thymoglobulin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	9.5%	37.5%	54.2%
	Zenapax	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	12.5%	4.2%
	Simulect	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	3.1%	4.2%
Corticosteroids	Category Usage	22.7%	15.8%	25.0%	52.9%	47.8%	90.9%	68.2%	71.4%	75.0%	83.3%
	Prednisone	13.6%	5.3%	18.8%	23.5%	17.4%	9.1%	22.7%	4.8%	37.5%	29.2%
	Methylprednisolone	13.6%	10.5%	12.5%	29.4%	30.4%	86.4%	59.1%	66.7%	50.0%	58.3%

Source: OPTN/SRTR Data as of August 1, 2002.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may be prescribed more than one drug within the same category.

Center-Specific Reports | OPO Reports | National Reports | Data Accuracy | Report Timeline

SRTR Site designed and maintained by Diamond Bullet Design & URREA.